Ribomic Inc.

Company Profile

Sector

Healthcare

Industry

Biotechnology

Employees

25

Website

www.ribomic.com

Country

Japan

Exchange

Tokyo

Tokyo, Japan

Ribomic Inc. discovers and develops pharmaceutical compounds using RNA aptamers in Japan. The company develops drugs for wet age-related macular degeneration, achondroplasia, pulmonary arterial hypertension, proliferative vitreoretinopathy, heart failure, osteoarthritis, and asthma Separating agents for affinity purification of human IgG and Fc-fusion proteins. Incorporated in 2003, the company is headquartered in Tokyo, Japan.

Key Stats

52-Week Range

¥57.00¥127.00

Beta0.18

Trailing P/EN/A

Forward P/E-1.33

Trailing EPS-23.07

Avg Volume

Earnings & Analyst

Next EarningsN/A

EPS EstimateN/A

Target Mean PriceN/A

RecommendationNone

Recommendation MeanN/A

Recent SEC Filings

SEC filings for this ticker are not available yet.